Clinical Research Directory
Browse clinical research sites, groups, and studies.
Novel Serum Biomarkers for Identifying Plaque Erosion in ACS and Predicting Prognosis
Sponsor: Xuebo Liu
Summary
The goal of this observational study is to find novel serum biomarkers for the accurate diagnosis of plaque erosion (PE) from acute coronary syndrome (ACS) and help predicting the prognosis of PE. The main question it aims to answer is • Whether novel serum biomarkers could facilitate the non-invasive diagnosis and prognosis prediction of PE ? Participants will be contacted at 1,2,5 year after the diagnosis of PE-ACS or other reasons of ACS.
Official title: Development and Validation of Diagnostic and Prognostic Model of Acute Coronary Syndrome Caused by Plaque Erosion Using Novel Serum Biomarkers
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
301
Start Date
2023-02-01
Completion Date
2026-07-30
Last Updated
2025-01-14
Healthy Volunteers
No
Conditions
Interventions
Blood is drawn to test for specific biomarkers
After identifying characteristic biomarkers that can distinguish between PE-ACS and PR-ACS, we draw blood from ACS patients for testing to assist in determining whether the ACS subtype is PE-ACS or PR-ACS.
Locations (1)
Tongji Hospital, Tongj University School of Medicine, 200333, Shanghai ,China
Shanghai, China